Is Now The Time To Sell Your Shares? Nuvilex Inc(OTCMKTS:NVLX), Kinder Morgan Management, LLC(NYSE:KMR), and Edap TMS SA (ADR)(NASDAQ:EDAP)
New York, NY – 08/15/2014 – HotStockGains provides investors and traders with valuable trading strategies via text message and email. To join our free text message alerts service just text the word BREAKOUT to 555888 from your cell phone. Just text STOP to unsubscribe if you ever need to.
Nuvilex Inc(OTCMKTS:NVLX) maintained its value during Thursday’s trading. While the stock traded within a range of $0.26 to $0.28 during the day, the Maryland-based biotechnology company still closed at a value of $0.269. The company currently has a market capitalization of $191.14 million with 709.26 million shares. Early Thursday morning, Nuvilex announced that Austrianova, the company’s partner, had reported results from the second Phase 2 clinical trial for the company’s Cell-in-a-Box(R) technology. According to the report, the “efficacious nature of Nuvilex’s pancreatic treatment” was apparent in both Phase 1 and Phase 2 trials.
Kinder Morgan Management, LLC(NYSE:KMR) closed at a value of $97.05 after gaining $2.64 during yesterday’s trading. The 2.8% increase in value came on a day when the company traded within a range of $94.55 to $97.39. The stock also saw its trading volume spike to a figure of 2,907,910, which is over 2.1 million higher than its three month average of 745,725. Kinder Morgan’s recent gains can be attributed to the consolidation of Kinder Morgan group into one entity.
Edap TMS SA (ADR)(NASDAQ:EDAP) gained eight cents during yesterday’s trading, a 4.88% increase in value that moved the stock to a closing price of $1.72. The stock, which traded within a range of $1.62 to $1.77 during the day, remains substantially closer to its 52 week low of $1.38 than it does to its high of $6.05. EDAP TMS SA will be hosting a second quarter financial results conference call on Aug. 28th, 2014. Class action lawsuits have been filed against the company due to the FDA’s ruling that the company’s Ablatherm-HIFU submission had failed to demonstrate the efficacy of its product.
I have a confession to make – I am not always right. Sometimes, unfortunately, I will send alerts that experience losses.
I have alerted companies that rallied 100% or even 6,000% (not even joking) in under a week. Likewise, I have alerted companies that tanked 10, 20, sometimes even as much as 30 or 40%. However overall it is about the net result that delivers profits into your portfolio.
Sign up for my free newsletter to receive market insight, tips, and trading strategies on NYSE, NASDAQ, OTCBB and PINK stocks. If you are not satisfied, simply click unsubscribe.
Disclosure: HotStockGains is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Always seek help from a professional financial advisor (I am not one). Please visit http://hotstockgains.com/disclaimer/ for complete risks and disclosures.